Tianshui Zhongxing Bio-technologyLtd Balance Sheet Health
Financial Health criteria checks 4/6
Tianshui Zhongxing Bio-technologyLtd has a total shareholder equity of CN¥3.4B and total debt of CN¥2.4B, which brings its debt-to-equity ratio to 71.6%. Its total assets and total liabilities are CN¥6.3B and CN¥2.9B respectively. Tianshui Zhongxing Bio-technologyLtd's EBIT is CN¥89.0M making its interest coverage ratio 2.2. It has cash and short-term investments of CN¥1.6B.
Key information
71.6%
Debt to equity ratio
CN¥2.44b
Debt
| Interest coverage ratio | 2.2x |
| Cash | CN¥1.63b |
| Equity | CN¥3.41b |
| Total liabilities | CN¥2.90b |
| Total assets | CN¥6.31b |
Recent financial health updates
No updates
Recent updates
Tianshui Zhongxing Bio-technologyLtd's (SZSE:002772) Anemic Earnings Might Be Worse Than You Think
Nov 02
These Return Metrics Don't Make Tianshui Zhongxing Bio-technologyLtd (SZSE:002772) Look Too Strong
Oct 01Tianshui Zhongxing Bio-technologyLtd (SZSE:002772) Has Affirmed Its Dividend Of CN¥0.30
May 12Tianshui Zhongxing Bio-technology Co.,Ltd. (SZSE:002772) Held Back By Insufficient Growth Even After Shares Climb 37%
Mar 15Financial Position Analysis
Short Term Liabilities: 002772's short term assets (CN¥3.0B) exceed its short term liabilities (CN¥1.4B).
Long Term Liabilities: 002772's short term assets (CN¥3.0B) exceed its long term liabilities (CN¥1.5B).
Debt to Equity History and Analysis
Debt Level: 002772's net debt to equity ratio (23.6%) is considered satisfactory.
Reducing Debt: 002772's debt to equity ratio has reduced from 74.1% to 71.6% over the past 5 years.
Debt Coverage: 002772's debt is not well covered by operating cash flow (17.1%).
Interest Coverage: 002772's interest payments on its debt are not well covered by EBIT (2.2x coverage).